This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Could Cataract Surgery Be A New Treatment Option for Primary Closed-Angle Glaucoma?

Data published in October 2016 shows there is a successful, safe, routine surgical procedure that has been restoring eyesight for ages, and it may be the answer to treating primary closed-angle glaucoma (PCAG).

Innovations in Microinvasive Techniques May Inspire New Pediatric Glaucoma Treatments

We need new and better treatments for pediatric glaucoma. Progress in micro-invasive techniques aimed at adults with glaucoma gives researchers reason to hope.

Glaucoma Biomarkers: from the Laboratory to the Clinic

Catalyst for a Cure researchers have been taking necessary steps to move their studies from the laboratory to the clinic.

New Nitric Oxide Medication to Reduce Intraocular Pressure Takes on Glaucoma from a New Angle

Nitric oxide has become a popular dietary supplement because it can help improve blood flow and lower blood pressure. As it turns out, nitric oxide also works as a glaucoma treatment.

Science Fiction May Hint at Vision-Restoring Prostheses for Glaucoma Patients

Researchers are developing and validating new technologies that could enable less invasive approaches for vision prosthetics.

Newly Funded Research Promoting Retinal Cell Axon Regeneration is Underway Thanks to NEI’s Audacious Goals Initiative

Optic nerve regeneration could be the answer to curing glaucoma, or at least substantially slowing the progression of the disease.

Danielle Fiarito: A Story of Hope and Inspiration

When Glaucoma Research Foundation (GRF) first learned of Danielle Fiarito, she was a teenager coping bravely with her disease.

Why Induced Pluripotent Stem Cells Are Vital for Glaucoma Research and Treatments

Stem cells are poised to make an impact on glaucoma research and treatment, as adult stem cells can be taken from the eye or skin, and used to try to replace damaged cells in your eye.

Frank Stein and Paul S. May: Devoted to Helping Families Thrive, Supporting People with Low Vision and Finding a Cure for Glaucoma

Frank and Paul strongly believe that research will ultimately lead to a cure for glaucoma.

Allergan Receives FDA Approval for XEN Glaucoma Treatment System

On November 22, 2016, Allergan announced that the U.S. Food and Drug Administration (FDA) has cleared the XEN® Glaucoma Treatment System for use in the United States.

Curing Glaucoma-related Vision Loss with High-contrast Visual Stimulation

A research study has found that high-contrast visual activity promotes optic nerve regrowth.

Research into Nerve Growth Factor for Glaucoma Offers New Hope for Treatment

Nerve regeneration focuses on ways to regrow nerves. Neuroprotection is preventing the death of nerve cells. Both goals must be developed before vision loss due to glaucoma can be stopped or reversed.

Chris Wilmoth and the Power of Family in Fighting Glaucoma

“Glaucoma Research Foundation is the best out there. They are ahead of the curve—they’re looking forward for the cure.” — Cathy Wilmoth

Saving Sight in Glaucoma: Why the Brain May Hold the Key

What causes vision loss in glaucoma? First is elevated ocular pressure, and second is damage to the optic nerve, which is the structure that sends visual information to the brain.

New Research Holds Promise For Restoring Lost Vision

Stanford researchers, funded in part by the National Eye Institute and the Glaucoma Research Foundation, make discovery that may help glaucoma patients who have lost vision.

GRF Scientific Advisors on Collaborative Research

Members of our Scientific Advisory Board talk about the success of the Catalyst for a Cure collaborative research model.

Personal Story: Pat Rospenda

“This disease must be conquered. I am taking its cure as a personal challenge.” — Pat Rospenda

What is MIGS?

The goal of all glaucoma surgery is to lower eye pressure. MIGS has become a commonly used abbreviation in the glaucoma world. It stands for minimally invasive glaucoma surgery.

Personal Story: Tracy Hammond

“When it comes to research, I give to Glaucoma Research Foundation.” — Tracy Hammond

Future Focus: Stem Cell Treatment for Glaucoma

Stem cells are undifferentiated cells which have the potential to develop into many different types of specialized tissues.

Ocular Hypertension Treatment

There are millions of people in the United States who have increased pressure in their eyes (intraocular pressure) without glaucoma. Often this condition is referred to as ocular hypertension.

Dr. Yvonne Ou discusses Lifestyle Modifications and Glaucoma

A glaucoma specialist answers questions glaucoma patients have regarding lifestyle modifications including diet, exercise, yoga, and acupuncture.

Catalyst for a Cure: Glaucoma Biomarker to Be Tested

The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for glaucoma.

Personal Story: Jenny Eisenberger

At age 32, Jenny learned that she had glaucoma from a routine eye exam.

Global Collaborations and Improving Glaucoma Care

Alan L. Robin, MD delivered the Robert N. Shaffer Lecture at the American Academy of Ophthalmology Annual Meeting in October 2014, Chicago, IL.